Tag: glaxosmithkline

FDA Panel Recommends Shingrix Shingles Vaccine

FDA Panel Recommends Shingrix Shingles Vaccine

GlaxoSmithKline's shingles vaccine Shingrix won unanimous approval from an advisory panel to the U.S. Food and Drug Administration (FDA), paving the way for the first alternative to Merck's Zostavax.

/ September 14, 2017